Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Caitlin E. Cox

December 06, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Daily News

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

L.A. McKeown

April 21, 2020

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

Less Not Always More When Medicating Frail, Elderly Acute MI Patients

L.A. McKeown

April 16, 2019

News Daily News

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

L.A. McKeown

April 19, 2018

News Daily News

Smartphone App May Help Acute MI Survivors Stay Out of the Hospital

L.A. McKeown

February 22, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

L.A. McKeown

June 30, 2017

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

Advertisement

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

October 2023 News Roundup

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Less Not Always More When Medicating Frail, Elderly Acute MI Patients

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

Smartphone App May Help Acute MI Survivors Stay Out of the Hospital

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Long-term Antiplatelet Therapy: All Risk, No Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content